Search

everythinglearnresearchcommunity

for

Search:↓

Artificial intelligence can accurately predict hair growth and treatment results in female pattern hair loss patients, with age of onset and duration being key factors.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Early onset female hair loss is linked to lower hair density, scalp issues, and certain genetic factors.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Women with and without hair loss have similar amounts of exogen hairs, so these hairs are not a key factor in hair loss conditions.

Bone Morphogenetic Proteins (BMPs) are important for hair growth, and their decrease due to hormones could lead to hair loss, but adding more BMPs could promote hair growth.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The document concludes that skin stem cells are important for hair growth and wound healing, and could be used in regenerative medicine.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Platelet-Rich Plasma (PRP) shows promise for hair growth and skin improvement in aesthetic surgery.

Adipose-derived stem cells show promise in treating skin conditions like vitiligo, alopecia, and nonhealing wounds.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Obesity in children can worsen skin issues and increase infection risk.

Advancements in skin and hair biology improve dermatology care and cosmetic treatments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Bald thigh syndrome in sighthounds is caused by structural defects in hair shafts due to downregulated genes and proteins.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Certain transcription factors are key in controlling skin stem cell behavior and could impact future treatments for skin repair and hair loss.

The hairless gene is crucial for hair health, and its mutations cause hair loss.